7th Edition of Neurology World Conference 2027
Scientific Sessions - NWC 2027
Neurological Biomarkers and Precision Medicine
Biomarkers are playing a growing role in how neurological diseases are diagnosed and treated. Blood tests such as p-tau217 now help identify Alzheimer's disease, while markers like neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) help track nerve damage in multiple sclerosis and other conditions. As these tests move from research labs into routine clinics, the field is attracting attention worldwide.
This track examines novel biomarkers from blood, cerebrospinal fluid, and genetic testing. Speakers will discuss how these markers support early, accurate diagnosis, track disease activity over time, and show whether treatment is working.
Whether you work in discovery research, clinical trials, or a hospital clinic, we want to hear how biomarkers are shaping your decisions.
Topics include:
- Blood-based biomarkers for neurological disease
- Cerebrospinal fluid markers
- Genetic testing and pharmacogenomics
- Biomarkers for treatment response and monitoring
- Validation and use in clinical practice
- Data, AI, and multi-marker approaches
- Personalized treatment strategies
Share your work and help bring care that fits each patient into everyday practice.
Related Sessions
Neurology World Conference (NWC 2027): Promotes the talks in From Research to ...
Read More>>
Organizer
